Select Publications
Journal articles
2019, 'The hygiene hypothesis, old friends, and new genes', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2019.00388
,2019, 'Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms', Therapeutic Advances in Chronic Disease, 10, http://dx.doi.org/10.1177/2040622319830646
,2018, 'A systematic review and critical evaluation of immunohistochemical associations in hidradenitis suppurativa', F1000Research, 7, http://dx.doi.org/10.12688/f1000research.17268.1
,2018, 'Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1', Australasian Journal of Dermatology, 59, pp. 267 - 277, http://dx.doi.org/10.1111/ajd.12770
,2018, 'New therapeutics for itch in dermatomyositis', British Journal of Dermatology, 179, pp. 559 - 560, http://dx.doi.org/10.1111/bjd.16811
,2018, 'HLA-B*1502 haplotype screening prior to carbamazepine administration in individuals of south-east Asian ancestry nears cost-effectiveness in preventing severe cutaneous adverse drug reactions', Australasian Journal of Dermatology, 59, pp. 245 - 246, http://dx.doi.org/10.1111/ajd.12754
,2018, 'Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?', Australasian Journal of Dermatology, 59, pp. e243 - e244, http://dx.doi.org/10.1111/ajd.12767
,2018, 'Secukinumab in pityriasis rubra pilaris: A case series demonstrating variable response and the need for minimal clinical datasets', JAAD Case Reports, 4, pp. 500 - 505, http://dx.doi.org/10.1016/j.jdcr.2018.02.007
,2018, 'Quality-of-Life Measures in Hidradenitis Suppurativa: The Importance of High-Quality Methodology and Standards', Journal of Cutaneous Medicine and Surgery, 22, pp. 368 - 368, http://dx.doi.org/10.1177/1203475418756372
,2018, 'BJD research letters: concise, thought provoking and of general interest', British Journal of Dermatology, 178, pp. 309 - 310, http://dx.doi.org/10.1111/bjd.16162
,2018, 'A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa .', F1000Research, 7, http://dx.doi.org/10.12688/f1000research.17267.1
,2018, 'Drug-associated hidradenitis suppurativa: A systematic review of case reports', Journal of the American Academy of Dermatology, 78, pp. 217 - 219.e2, http://dx.doi.org/10.1016/j.jaad.2017.08.046
,2018, 'A systematic review and critical evaluation of immunohistochemical associations in hidradenitis suppurativa.', F1000Res, 7, pp. 1923, http://dx.doi.org/10.12688/f1000research.17268.2
,2018, 'A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa.', F1000Research, 7, pp. 1930, http://dx.doi.org/10.12688/f1000research.17267.1
,2017, 'Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: A systematic review and critical evaluation', Orphanet Journal of Rare Diseases, 12, pp. 189, http://dx.doi.org/10.1186/s13023-017-0739-5
,2017, 'Lichen amyloidosis involving the scalp', Australasian Journal of Dermatology, 58, pp. e260 - e261, http://dx.doi.org/10.1111/ajd.12582
,2017, 'A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa', British Journal of Dermatology, 177, pp. 987 - 998, http://dx.doi.org/10.1111/bjd.15441
,2017, 'Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis', Skin Appendage Disorders, 3, pp. 179 - 181, http://dx.doi.org/10.1159/000464140
,2017, 'Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration.', Australas J Dermatol, 59, pp. 86 - 100, http://dx.doi.org/10.1111/ajd.12641
,2017, 'News and Notices', British Journal of Dermatology, 177, pp. 599 - 601, http://dx.doi.org/10.1111/bjd.15851
,2016, 'Beyond the tip of the iceberg: The role of phosphoinositide 3-kinase/AKT in acne inversa/hidradenitis suppurativa', British Journal of Dermatology, 174, pp. 484 - 485, http://dx.doi.org/10.1111/bjd.14349
,2016, 'The early bird and the worm: a case of cercarial dermatitis', MEDICAL JOURNAL OF AUSTRALIA, 204, pp. 122 - 1230, http://dx.doi.org/10.5694/mja15.00802
,2016, 'Adopting the orphan: The importance of recognising hidradenitis suppurativa as a systemic auto-inflammatory disease', Australasian Journal of Dermatology, 57, pp. 69 - 70, http://dx.doi.org/10.1111/ajd.12287
,2016, 'The early bird and the worm: a case of cercarial dermatitis', Medical Journal of Australia, 204, pp. 122 - 123, http://dx.doi.org/10.5694/MJA15.00802
,2015, 'Fifty shades of yellow: A review of the xanthodermatoses', International Journal of Dermatology, 54, pp. 1109 - 1123, http://dx.doi.org/10.1111/ijd.12945
,2015, 'Tattoo-associated mycobacterial infections: an emerging public health issue', Medical Journal of Australia, 203, pp. 223 - 223e.1, http://dx.doi.org/10.5694/MJA15.00098
,2015, 'Adalimumab-induced porokeratosis', Australasian Journal of Dermatology, 56, pp. e80 - e81, http://dx.doi.org/10.1111/ajd.12215
,2015, 'Phenotypic heterogeneity implies heterogeneous pathogenic pathways in hidradenitis suppurativa', Experimental Dermatology, 24, pp. 338 - 339, http://dx.doi.org/10.1111/exd.12648
,2015, 'Multinucleate cell angiohistiocytoma: Clinicopathological correlation of 142 cases with insights into etiology and pathogenesis', American Journal of Dermatopathology, 37, pp. 222 - 228, http://dx.doi.org/10.1097/DAD.0000000000000075
,2015, 'Chlorophyll-induced pseudoporphyria with ongoing photosensitivity after cessation - a case series of four patients', Journal of the European Academy of Dermatology and Venereology, pp. n/a - n/a, http://dx.doi.org/10.1111/jdv.13169
,2014, 'Adalimumab-induced porokeratosis', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 55, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Health-related quality of life in epidermolysis bullosa: Validation of the dutch QOLEB questionnaire and assessment in the dutch population', Acta Dermato-Venereologica, 94, pp. 442 - 447, http://dx.doi.org/10.2340/00015555-1758
,2014, 'The clinical significance of drug interactions between dermatological and psychoactive medications', Dermatologic Therapy, 27, pp. 1 - 11, http://dx.doi.org/10.1111/dth.12003
,2013, 'The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease', British Journal of Dermatology, 169, pp. 1000 - 1006, http://dx.doi.org/10.1111/bjd.12623
,2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972
,2013, 'Cross cultural adaptation of the 'Quality of Life in Epidermolysis Bullosa' (QOLEB) questionnaire: Validation and results of a Hispanic translation', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa', Journal of the American Academy of Dermatology, 69, http://dx.doi.org/10.1016/j.jaad.2013.08.014
,2013, 'Measuring quality of life in epidermolysis bullosa in Mexico: Cross-cultural validation of the Hispanic version of the Quality of Life in Epidermolysis Bullosa questionnaire', Journal of the American Academy of Dermatology, 69, pp. 652 - 653, http://dx.doi.org/10.1016/j.jaad.2013.04.053
,2013, 'Diffuse melanosis cutis: A systematic review of the literature', Journal of the American Academy of Dermatology, 68, pp. 482 - 488, http://dx.doi.org/10.1016/j.jaad.2012.08.018
,2012, 'INVESTIGATION OF CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB) THROUGH INTRADERMAL INJECTION OF ALLOGENEIC FIBROBLASTS RANDOMIZED AGAINST PLACEBO INJECTIONS OF SUSPENSION SOLUTION', WOUND REPAIR AND REGENERATION, 20, pp. A68 - A68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'VALIDATION OF THE PSYCHOMETRIC PROPERTIES OF A QUALITY-OF-LIFE MEASURE SPECIFIC TO AUTOIMMUNE BULLOUS DISEASE', WOUND REPAIR AND REGENERATION, 20, pp. A65 - A65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Corticosteroid Use in Autoimmune Blistering Diseases', Immunology and Allergy Clinics of North America, 32, pp. 283 - 294, http://dx.doi.org/10.1016/j.iac.2012.04.008
,2012, 'Quality-of-Life Measurement in Blistering Diseases', Dermatologic Clinics, 30, pp. 301 - 307, http://dx.doi.org/10.1016/j.det.2011.11.008
,2011, 'Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagen.', Australasian Journal of Dermatology, 52, pp. e1 - e4, http://dx.doi.org/10.1111/j.1440-0960.2010.00684.x
,2011, 'Corticosteroid Use in Autoimmune Blistering Diseases', Dermatologic Clinics, 29, pp. 535 - 544, http://dx.doi.org/10.1016/j.det.2011.06.004
,2011, 'Current Management Strategies in Paraneoplastic Pemphigus (Paraneoplastic Autoimmune Multiorgan Syndrome)', Dermatologic Clinics, 29, pp. 607 - 612, http://dx.doi.org/10.1016/j.det.2011.06.016
,2011, 'Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus', Dermatologic Clinics, 29, pp. 599 - 606, http://dx.doi.org/10.1016/j.det.2011.07.001
,2011, 'Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis', Dermatologic Clinics, 29, pp. 419 - 425, http://dx.doi.org/10.1016/j.det.2011.03.018
,2010, 'Categorizing immunoflourescence mapping in epidermolysis bullosa with pyloric atresia: Use as a broad prognostic indicator', Australasian Journal of Dermatology, 51, pp. 212 - 214, http://dx.doi.org/10.1111/j.1440-0960.2010.00666.x
,2010, 'TRIAL OF FIBROBLAST CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 18, pp. A74 - A74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279454700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,